2018
DOI: 10.1016/j.comtox.2018.06.002
|View full text |Cite
|
Sign up to set email alerts
|

A pharma-wide approach to address the genotoxicity prediction of primary aromatic amines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(32 citation statements)
references
References 21 publications
0
30
0
2
Order By: Relevance
“…The prediction accuracies of commercial QSAR tools for primary aromatic amines are 59 to 64% for 599 test compounds and can be improved to about 63 to 79% by adding new data sets and revising the rules [ 4 ]. For another 268 test compounds, the reported accuracy ranged from 57 to 73% [ 5 ].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…The prediction accuracies of commercial QSAR tools for primary aromatic amines are 59 to 64% for 599 test compounds and can be improved to about 63 to 79% by adding new data sets and revising the rules [ 4 ]. For another 268 test compounds, the reported accuracy ranged from 57 to 73% [ 5 ].…”
Section: Resultsmentioning
confidence: 99%
“…The prediction accuracy of QSAR tools is improved by increasing the number of training sets and modifying algorithms [ 2 , 3 ]. However, the mutagenicity of several structures, such as aromatic amines, is still difficult to predict when using QSAR tools [ 4 , 5 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The comments accompanying the Derek Nexus prediction suggest compound 1 narrowly misses an exclusion and also highlights the borderline mutagenic activity of multiply substituted aromatic amines and amides, making them a significant challenge to in silico tools [ 21 ]. Derek Nexus described that activity is expected to result from metabolic activation, initially to the amine.…”
Section: Introductionmentioning
confidence: 99%